Here, we showed that TGF-β1 strongly induces the EMT and Smad/non-Smad signaling pathways of NSCLC A549 cells, and as a receptor tyrosine kinase (RTK) inhibitor sunitinib significantly inhibited these inductions. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.